{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-012666","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.675022+00:00","generated_at":"2026-06-25T23:19:25.085657+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ApolloMed Q1 revenue up 50% to $263M; raises FY guidance; appoints new CFO","bullets":["Q1 revenue $263.3M, up 50% YoY; net income attributable to ApolloMed $14.3M (+8%); adj. EBITDA $38.2M (+25%).","FY guidance raised: revenue $1,055M–$1,085M; adj. EBITDA $136M–$166M (previous low $130M).","CFO Eric Chin steps down for personal reasons; Chan Basho appointed Interim CFO and Chief Strategy Officer.","Basho's compensation: $300k base, $200k sign-on bonus, $1.2M initial restricted stock award.","Completed acquisition of Jade Health Care Medical Group, adding ~13,000 Medicare/Medicaid members."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-012666","json":"https://secwatch.observer/filing/0001628280-22-012666.json","markdown":"https://secwatch.observer/filing/0001628280-22-012666.md","text":"https://secwatch.observer/filing/0001628280-22-012666.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/0001628280-22-012666-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/ameh-20220505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:19:25.085657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bf109a46d1","claim":"Eric Chin departed as Chief Financial Officer at Astrana Health, Inc..","evidence_excerpt":"In connection with the appointment, Eric Chin will step down for personal reasons as Chief Financial Officer effective May 5, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/0001628280-22-012666-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"e6002aa523","claim":"Chan Basho was appointed as Interim Chief Financial Officer at Astrana Health, Inc..","evidence_excerpt":"On May 5, 2022, the Company appointed Chan Basho as the Company's Interim Chief Financial Officer, effective May 5, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/0001628280-22-012666-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}